IMGN(Delisted)
ImmunoGenยทNASDAQ
--
--(--)
IMGN fundamentals
ImmunoGen (IMGN) released its earnings on Nov 3, 2017: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Nov 3, 2017
EPS
Revenue
Revenue & Expenses
IMGN has released its 2023 Q3 earnings report, with revenue of 113.42M, reflecting a YoY change of 637.72%, and net profit of 30.75M, showing a YoY change of 139.54%. The Sankey diagram below clearly presents IMGN's revenue sources and cost distribution.
Key Indicators
ImmunoGen (IMGN) key financial stats and ratios, covering profitability, financial health, and leverage.
ImmunoGen (IMGN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
ImmunoGen (IMGN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
ImmunoGen (IMGN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does ImmunoGen (IMGN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track ImmunoGen (IMGN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
